| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.53B | $1.09B | $1.02B |
| YoY Revenue Growth % | +40.6% | +6.9% | — |
| Gross Profit | $304.1M | $228.2M | — |
| Gross Margin % | 19.9% | 21.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $73.1M | $68.5M | $59.0M |
| Operating Margin % | 4.8% | 6.3% | 5.8% |
| Net Income (GAAP) | $9.7M | $30.7M | $11.2M |
| EBITDA (Normalized) | $84.4M | $79.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $9.0M | $68.8M | $30.1M |
| Capital Expenditures (CapEx) | $14.2M | $13.6M | — |
| Free Cash Flow (FCF) | -$5.2M | $55.2M | $30.1M |
| FCF Margin % | -0.3% | 5.1% | 3.0% |
| Return on Invested Capital (ROIC %) | 4.6% | 8.0% | — |
| Cash & Short-Term Equivalents | $98.5M | $65.2M | — |
| Total Debt (Short + Long Term) | $548.0M | $376.6M | — |
| Total Stockholders' Equity | $814.9M | $365.1M | — |